ALDH1 has been reported to play a role in promoting triple-negative breast cancer progression and enhanced drug resistance in a Notch receptor 4 (NOTCH4)-dependent manner (32, 33). This evidence concerns the gene ALDH1A1 and triple-negative breast carcinoma.